Patent for Poolbeg's immunomodulator aimed at treating hypercytokinaemia
Poolbeg Pharma plc has been granted a patent by the US Patent and Trademark Office (USPTO) for ways of treating hypercytokinaemia using a small molecule immunomodulator.
Archives for March 13, 2023
Janssen dual action tablet for prostate cancer gets recommended marketing authorization
Small molecule drug, Niraparib combined with abiraterone acetate (AA) and prednisone (P) significantly reduces the risk of disease progression, or death, in patients with a type of prostate cancer, a consultant in Spain has said.
International gang including UK criminals sentenced for illegal supply and sale of prescription drugs
Two men have been jailed and another handed a suspended sentence, for selling more than three million doses of prescription-only and unlicensed medicines, including controlled medicines.